nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—Gangrene—Hydroxyurea—psoriasis	0.0731	0.0968	CcSEcCtD
Norepinephrine—Gangrene—Mycophenolate mofetil—psoriasis	0.0483	0.064	CcSEcCtD
Norepinephrine—Hypovolaemia—Mycophenolic acid—psoriasis	0.0431	0.0571	CcSEcCtD
Norepinephrine—Hypovolaemia—Mycophenolate mofetil—psoriasis	0.034	0.0451	CcSEcCtD
Norepinephrine—Retrosternal pain—Mycophenolate mofetil—psoriasis	0.0262	0.0347	CcSEcCtD
Norepinephrine—Photophobia—Calcitriol—psoriasis	0.0214	0.0284	CcSEcCtD
Norepinephrine—Photophobia—Acitretin—psoriasis	0.0191	0.0253	CcSEcCtD
Norepinephrine—Photophobia—Fluocinolone Acetonide—psoriasis	0.019	0.0252	CcSEcCtD
Norepinephrine—Pallor—Mycophenolic acid—psoriasis	0.0161	0.0214	CcSEcCtD
Norepinephrine—Blood pressure increased—Mycophenolic acid—psoriasis	0.0134	0.0177	CcSEcCtD
Norepinephrine—Pallor—Mycophenolate mofetil—psoriasis	0.0127	0.0169	CcSEcCtD
Norepinephrine—Arrhythmia—Methoxsalen—psoriasis	0.0115	0.0152	CcSEcCtD
Norepinephrine—Arrhythmia—Calcitriol—psoriasis	0.0102	0.0136	CcSEcCtD
Norepinephrine—Photophobia—Mycophenolate mofetil—psoriasis	0.0099	0.0131	CcSEcCtD
Norepinephrine—Extravasation—Dexamethasone—psoriasis	0.00941	0.0125	CcSEcCtD
Norepinephrine—Extravasation—Betamethasone—psoriasis	0.00941	0.0125	CcSEcCtD
Norepinephrine—Hypertension—Calcitriol—psoriasis	0.00862	0.0114	CcSEcCtD
Norepinephrine—Chest pain—Calcitriol—psoriasis	0.0085	0.0113	CcSEcCtD
Norepinephrine—Anxiety—Calcitriol—psoriasis	0.00847	0.0112	CcSEcCtD
Norepinephrine—Headache—Clobetasol propionate—psoriasis	0.00805	0.0107	CcSEcCtD
Norepinephrine—Chest pain—Acitretin—psoriasis	0.00756	0.01	CcSEcCtD
Norepinephrine—Anxiety—Acitretin—psoriasis	0.00754	0.00999	CcSEcCtD
Norepinephrine—Headache—Beclomethasone—psoriasis	0.00732	0.0097	CcSEcCtD
Norepinephrine—Headache—Fluocinonide—psoriasis	0.00726	0.00961	CcSEcCtD
Norepinephrine—Sweating—Mycophenolic acid—psoriasis	0.00717	0.00949	CcSEcCtD
Norepinephrine—Hyperhidrosis—Acitretin—psoriasis	0.00701	0.00929	CcSEcCtD
Norepinephrine—Extravasation—Methotrexate—psoriasis	0.00685	0.00907	CcSEcCtD
Norepinephrine—Bradycardia—Mycophenolic acid—psoriasis	0.00683	0.00905	CcSEcCtD
Norepinephrine—Arrhythmia—Mycophenolic acid—psoriasis	0.00599	0.00794	CcSEcCtD
Norepinephrine—Headache—Methoxsalen—psoriasis	0.00573	0.00759	CcSEcCtD
Norepinephrine—Sweating—Mycophenolate mofetil—psoriasis	0.00566	0.00749	CcSEcCtD
Norepinephrine—Bradycardia—Mycophenolate mofetil—psoriasis	0.00539	0.00714	CcSEcCtD
Norepinephrine—Vomiting—Calcitriol—psoriasis	0.00518	0.00687	CcSEcCtD
Norepinephrine—Headache—Calcitriol—psoriasis	0.00511	0.00676	CcSEcCtD
Norepinephrine—Dyspnoea—Hydroxyurea—psoriasis	0.00507	0.00672	CcSEcCtD
Norepinephrine—Hypertension—Mycophenolic acid—psoriasis	0.00504	0.00668	CcSEcCtD
Norepinephrine—Bradycardia—Prednisolone—psoriasis	0.00503	0.00666	CcSEcCtD
Norepinephrine—Chest pain—Mycophenolic acid—psoriasis	0.00497	0.00659	CcSEcCtD
Norepinephrine—Anxiety—Mycophenolic acid—psoriasis	0.00496	0.00657	CcSEcCtD
Norepinephrine—Bradycardia—Hydrocortisone—psoriasis	0.00491	0.00651	CcSEcCtD
Norepinephrine—Arrhythmia—Cyclosporine—psoriasis	0.00485	0.00642	CcSEcCtD
Norepinephrine—Arrhythmia—Mycophenolate mofetil—psoriasis	0.00473	0.00627	CcSEcCtD
Norepinephrine—Bradycardia—Triamcinolone—psoriasis	0.00462	0.00613	CcSEcCtD
Norepinephrine—Vomiting—Acitretin—psoriasis	0.00461	0.00611	CcSEcCtD
Norepinephrine—Hyperhidrosis—Mycophenolic acid—psoriasis	0.00461	0.00611	CcSEcCtD
Norepinephrine—Vomiting—Fluocinolone Acetonide—psoriasis	0.0046	0.00609	CcSEcCtD
Norepinephrine—Headache—Acitretin—psoriasis	0.00454	0.00602	CcSEcCtD
Norepinephrine—Headache—Fluocinolone Acetonide—psoriasis	0.00453	0.006	CcSEcCtD
Norepinephrine—Arrhythmia—Prednisolone—psoriasis	0.00441	0.00585	CcSEcCtD
Norepinephrine—Arrhythmia—Hydrocortisone—psoriasis	0.00431	0.00571	CcSEcCtD
Norepinephrine—Dyspnoea—Mycophenolic acid—psoriasis	0.00425	0.00563	CcSEcCtD
Norepinephrine—Bradycardia—Betamethasone—psoriasis	0.0042	0.00556	CcSEcCtD
Norepinephrine—Bradycardia—Dexamethasone—psoriasis	0.0042	0.00556	CcSEcCtD
Norepinephrine—Hypertension—Cyclosporine—psoriasis	0.00408	0.00541	CcSEcCtD
Norepinephrine—Arrhythmia—Triamcinolone—psoriasis	0.00406	0.00538	CcSEcCtD
Norepinephrine—Chest pain—Cyclosporine—psoriasis	0.00402	0.00533	CcSEcCtD
Norepinephrine—Anxiety—Cyclosporine—psoriasis	0.00401	0.00531	CcSEcCtD
Norepinephrine—Hypertension—Mycophenolate mofetil—psoriasis	0.00398	0.00527	CcSEcCtD
Norepinephrine—Chest pain—Mycophenolate mofetil—psoriasis	0.00392	0.0052	CcSEcCtD
Norepinephrine—Anxiety—Mycophenolate mofetil—psoriasis	0.00391	0.00518	CcSEcCtD
Norepinephrine—Hyperhidrosis—Cyclosporine—psoriasis	0.00373	0.00494	CcSEcCtD
Norepinephrine—Hypertension—Prednisolone—psoriasis	0.00371	0.00492	CcSEcCtD
Norepinephrine—Arrhythmia—Betamethasone—psoriasis	0.00368	0.00488	CcSEcCtD
Norepinephrine—Arrhythmia—Dexamethasone—psoriasis	0.00368	0.00488	CcSEcCtD
Norepinephrine—Bradycardia—Prednisone—psoriasis	0.00365	0.00484	CcSEcCtD
Norepinephrine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.00364	0.00482	CcSEcCtD
Norepinephrine—Hypertension—Hydrocortisone—psoriasis	0.00363	0.0048	CcSEcCtD
Norepinephrine—Vomiting—Hydroxyurea—psoriasis	0.00362	0.00479	CcSEcCtD
Norepinephrine—Headache—Hydroxyurea—psoriasis	0.00357	0.00472	CcSEcCtD
Norepinephrine—Anxiety—Hydrocortisone—psoriasis	0.00356	0.00472	CcSEcCtD
Norepinephrine—Dyspnoea—Cyclosporine—psoriasis	0.00344	0.00456	CcSEcCtD
Norepinephrine—Hypertension—Triamcinolone—psoriasis	0.00341	0.00452	CcSEcCtD
Norepinephrine—Hyperhidrosis—Prednisolone—psoriasis	0.00339	0.00449	CcSEcCtD
Norepinephrine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00335	0.00444	CcSEcCtD
Norepinephrine—Hyperhidrosis—Hydrocortisone—psoriasis	0.00331	0.00439	CcSEcCtD
Norepinephrine—Arrhythmia—Prednisone—psoriasis	0.00321	0.00425	CcSEcCtD
Norepinephrine—Sweating—Methotrexate—psoriasis	0.0032	0.00424	CcSEcCtD
Norepinephrine—Hyperhidrosis—Triamcinolone—psoriasis	0.00312	0.00413	CcSEcCtD
Norepinephrine—Hypertension—Dexamethasone—psoriasis	0.0031	0.0041	CcSEcCtD
Norepinephrine—Hypertension—Betamethasone—psoriasis	0.0031	0.0041	CcSEcCtD
Norepinephrine—Anxiety—Dexamethasone—psoriasis	0.00304	0.00403	CcSEcCtD
Norepinephrine—Anxiety—Betamethasone—psoriasis	0.00304	0.00403	CcSEcCtD
Norepinephrine—Vomiting—Mycophenolic acid—psoriasis	0.00303	0.00402	CcSEcCtD
Norepinephrine—Headache—Mycophenolic acid—psoriasis	0.00299	0.00396	CcSEcCtD
Norepinephrine—Dyspnoea—Triamcinolone—psoriasis	0.00288	0.00381	CcSEcCtD
Norepinephrine—Hyperhidrosis—Dexamethasone—psoriasis	0.00283	0.00375	CcSEcCtD
Norepinephrine—Hyperhidrosis—Betamethasone—psoriasis	0.00283	0.00375	CcSEcCtD
Norepinephrine—Hypertension—Prednisone—psoriasis	0.0027	0.00357	CcSEcCtD
Norepinephrine—Anxiety—Prednisone—psoriasis	0.00265	0.00351	CcSEcCtD
Norepinephrine—Hyperhidrosis—Prednisone—psoriasis	0.00247	0.00327	CcSEcCtD
Norepinephrine—Vomiting—Cyclosporine—psoriasis	0.00245	0.00325	CcSEcCtD
Norepinephrine—Headache—Cyclosporine—psoriasis	0.00242	0.0032	CcSEcCtD
Norepinephrine—Vomiting—Mycophenolate mofetil—psoriasis	0.00239	0.00317	CcSEcCtD
Norepinephrine—Headache—Mycophenolate mofetil—psoriasis	0.00236	0.00312	CcSEcCtD
Norepinephrine—Chest pain—Methotrexate—psoriasis	0.00222	0.00295	CcSEcCtD
Norepinephrine—Headache—Prednisolone—psoriasis	0.0022	0.00291	CcSEcCtD
Norepinephrine—Vomiting—Hydrocortisone—psoriasis	0.00218	0.00289	CcSEcCtD
Norepinephrine—Headache—Hydrocortisone—psoriasis	0.00215	0.00284	CcSEcCtD
Norepinephrine—Hyperhidrosis—Methotrexate—psoriasis	0.00206	0.00273	CcSEcCtD
Norepinephrine—Vomiting—Triamcinolone—psoriasis	0.00205	0.00272	CcSEcCtD
Norepinephrine—Headache—Triamcinolone—psoriasis	0.00202	0.00268	CcSEcCtD
Norepinephrine—Dyspnoea—Methotrexate—psoriasis	0.0019	0.00252	CcSEcCtD
Norepinephrine—Vomiting—Dexamethasone—psoriasis	0.00186	0.00247	CcSEcCtD
Norepinephrine—Vomiting—Betamethasone—psoriasis	0.00186	0.00247	CcSEcCtD
Norepinephrine—Headache—Dexamethasone—psoriasis	0.00183	0.00243	CcSEcCtD
Norepinephrine—Headache—Betamethasone—psoriasis	0.00183	0.00243	CcSEcCtD
Norepinephrine—Vomiting—Prednisone—psoriasis	0.00162	0.00215	CcSEcCtD
Norepinephrine—Headache—Prednisone—psoriasis	0.0016	0.00212	CcSEcCtD
Norepinephrine—Vomiting—Methotrexate—psoriasis	0.00136	0.0018	CcSEcCtD
Norepinephrine—Headache—Methotrexate—psoriasis	0.00134	0.00177	CcSEcCtD
Norepinephrine—PAH—Disease—TYK2—psoriasis	0.000239	0.000973	CbGpPWpGaD
Norepinephrine—ADRA2B—G alpha (i) signalling events—CXCL8—psoriasis	0.000238	0.000972	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HCAR2—psoriasis	0.000237	0.000965	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CCL20—psoriasis	0.000233	0.000948	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TAGAP—psoriasis	0.000229	0.000935	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CCL20—psoriasis	0.000229	0.000935	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—PPARG—psoriasis	0.000228	0.00093	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CCL20—psoriasis	0.000224	0.000914	CbGpPWpGaD
Norepinephrine—ADRA2C—G alpha (i) signalling events—CXCL8—psoriasis	0.000223	0.000908	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TAGAP—psoriasis	0.000221	0.000901	CbGpPWpGaD
Norepinephrine—PAH—Disease—CD4—psoriasis	0.000216	0.00088	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—JUN—psoriasis	0.000213	0.000868	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00021	0.000856	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CCL20—psoriasis	0.000208	0.000849	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TAGAP—psoriasis	0.000205	0.000837	CbGpPWpGaD
Norepinephrine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000203	0.00083	CbGpPWpGaD
Norepinephrine—DRD2—G alpha (i) signalling events—CXCL8—psoriasis	0.000202	0.000824	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000191	0.00078	CbGpPWpGaD
Norepinephrine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.00019	0.000775	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00019	0.000773	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000187	0.000763	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—NOS2—psoriasis	0.000181	0.000738	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—CXCL8—psoriasis	0.000181	0.000738	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCL20—psoriasis	0.00018	0.000732	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000177	0.000722	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000174	0.000711	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—NOS2—psoriasis	0.000169	0.00069	CbGpPWpGaD
Norepinephrine—PAH—Disease—STAT3—psoriasis	0.000167	0.000681	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NDUFA5—psoriasis	0.000166	0.000678	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL20—psoriasis	0.000164	0.000667	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL20—psoriasis	0.000162	0.000661	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000161	0.000655	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL20—psoriasis	0.00016	0.000653	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—CXCL8—psoriasis	0.00016	0.000652	CbGpPWpGaD
Norepinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000159	0.00065	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CARM1—psoriasis	0.000158	0.000645	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—CAT—psoriasis	0.000155	0.000633	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000155	0.000632	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000155	0.000631	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000154	0.000629	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CARM1—psoriasis	0.000154	0.000628	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—SOCS1—psoriasis	0.000152	0.000619	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL20—psoriasis	0.000151	0.000617	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL20—psoriasis	0.000149	0.000608	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CARM1—psoriasis	0.000148	0.000602	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—CXCL8—psoriasis	0.000146	0.000594	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—TYK2—psoriasis	0.000145	0.00059	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—CXCL8—psoriasis	0.000144	0.000589	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000144	0.000587	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—CXCL8—psoriasis	0.000143	0.000581	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP2S1—psoriasis	0.000141	0.000576	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—TP53—psoriasis	0.000141	0.000573	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—CXCL8—psoriasis	0.000139	0.000566	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL20—psoriasis	0.000137	0.00056	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—NOS2—psoriasis	0.000137	0.00056	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—CXCL8—psoriasis	0.000135	0.00055	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—CXCL8—psoriasis	0.000133	0.000541	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL20—psoriasis	0.000132	0.00054	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000132	0.000539	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—IL6—psoriasis	0.000129	0.000525	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—CXCL8—psoriasis	0.000126	0.000514	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CARM1—psoriasis	0.000125	0.00051	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL20—psoriasis	0.000123	0.000501	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—CXCL8—psoriasis	0.000122	0.000499	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—APOE—psoriasis	0.000121	0.000492	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—CXCL8—psoriasis	0.000118	0.000481	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000117	0.000479	CbGpPWpGaD
Norepinephrine—PAH—Disease—IL6—psoriasis	0.000117	0.000476	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—APOE—psoriasis	0.000112	0.000457	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—LEP—psoriasis	0.000112	0.000457	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	0.00011	0.000447	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—PPARG—psoriasis	0.000105	0.000428	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—VEGFA—psoriasis	0.000105	0.000428	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—NFKBIA—psoriasis	0.000104	0.000426	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SOCS1—psoriasis	9.88e-05	0.000403	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—VEGFA—psoriasis	9.79e-05	0.000399	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CAT—psoriasis	9.73e-05	0.000397	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CAT—psoriasis	9.47e-05	0.000386	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—TYK2—psoriasis	9.42e-05	0.000384	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CAT—psoriasis	9.07e-05	0.00037	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—CXCL8—psoriasis	9.04e-05	0.000369	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SOCS1—psoriasis	9.01e-05	0.000367	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SOCS1—psoriasis	8.92e-05	0.000364	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SOCS1—psoriasis	8.81e-05	0.000359	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—TYK2—psoriasis	8.59e-05	0.00035	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TYK2—psoriasis	8.55e-05	0.000349	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—TYK2—psoriasis	8.51e-05	0.000347	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—TYK2—psoriasis	8.4e-05	0.000343	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SOCS1—psoriasis	8.34e-05	0.00034	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	8.23e-05	0.000336	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	8.21e-05	0.000335	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SOCS1—psoriasis	8.2e-05	0.000335	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	8.16e-05	0.000333	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—CXCL8—psoriasis	8.05e-05	0.000328	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—VEGFA—psoriasis	7.96e-05	0.000324	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—TYK2—psoriasis	7.95e-05	0.000324	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TP53—psoriasis	7.92e-05	0.000323	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—TYK2—psoriasis	7.82e-05	0.000319	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CAT—psoriasis	7.69e-05	0.000314	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	7.62e-05	0.000311	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—APOE—psoriasis	7.56e-05	0.000308	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SOCS1—psoriasis	7.56e-05	0.000308	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	7.5e-05	0.000306	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CXCL8—psoriasis	7.48e-05	0.000305	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CXCL8—psoriasis	7.44e-05	0.000303	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	7.41e-05	0.000302	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.41e-05	0.000302	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TP53—psoriasis	7.4e-05	0.000302	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—APOE—psoriasis	7.36e-05	0.0003	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CXCL8—psoriasis	7.31e-05	0.000298	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—APOE—psoriasis	7.29e-05	0.000298	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—LEP—psoriasis	7.29e-05	0.000298	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	7.29e-05	0.000297	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—TYK2—psoriasis	7.21e-05	0.000294	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—IL6—psoriasis	7.08e-05	0.000289	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—APOE—psoriasis	7.05e-05	0.000288	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	6.95e-05	0.000283	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	6.92e-05	0.000282	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—JUN—psoriasis	6.92e-05	0.000282	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	6.91e-05	0.000282	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CARM1—psoriasis	6.9e-05	0.000282	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	6.81e-05	0.000278	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	6.8e-05	0.000277	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	6.77e-05	0.000276	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	6.66e-05	0.000272	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—NFKB1—psoriasis	6.66e-05	0.000272	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APOE—psoriasis	6.65e-05	0.000271	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—LEP—psoriasis	6.65e-05	0.000271	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PPARG—psoriasis	6.59e-05	0.000269	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—LEP—psoriasis	6.59e-05	0.000269	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APOE—psoriasis	6.59e-05	0.000269	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—LEP—psoriasis	6.5e-05	0.000265	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APOE—psoriasis	6.5e-05	0.000265	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	6.46e-05	0.000263	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.45e-05	0.000263	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PPARG—psoriasis	6.41e-05	0.000261	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CXCL8—psoriasis	6.28e-05	0.000256	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NFKBIA—psoriasis	6.19e-05	0.000253	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	6.19e-05	0.000252	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APOE—psoriasis	6.15e-05	0.000251	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—LEP—psoriasis	6.15e-05	0.000251	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PPARG—psoriasis	6.14e-05	0.00025	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	6.14e-05	0.00025	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NFKBIA—psoriasis	6.06e-05	0.000247	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—LEP—psoriasis	6.05e-05	0.000247	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APOE—psoriasis	6.05e-05	0.000247	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	6.05e-05	0.000247	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—VEGFA—psoriasis	6.04e-05	0.000246	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TP53—psoriasis	6.01e-05	0.000245	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—STAT3—psoriasis	5.98e-05	0.000244	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOE—psoriasis	5.98e-05	0.000244	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	5.73e-05	0.000234	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	5.64e-05	0.00023	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	5.62e-05	0.000229	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—LEP—psoriasis	5.58e-05	0.000228	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOE—psoriasis	5.58e-05	0.000228	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TYK2—psoriasis	5.57e-05	0.000227	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—psoriasis	5.38e-05	0.000219	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—LEP—psoriasis	5.38e-05	0.000219	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PPARG—psoriasis	5.21e-05	0.000212	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NFKBIA—psoriasis	5.2e-05	0.000212	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TYK2—psoriasis	5.07e-05	0.000207	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TYK2—psoriasis	5.03e-05	0.000205	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	5.01e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—LEP—psoriasis	5e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—psoriasis	5e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TYK2—psoriasis	4.96e-05	0.000202	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	4.85e-05	0.000198	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TYK2—psoriasis	4.7e-05	0.000191	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	4.66e-05	0.00019	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TYK2—psoriasis	4.62e-05	0.000188	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—psoriasis	4.61e-05	0.000188	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—psoriasis	4.57e-05	0.000186	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—JUN—psoriasis	4.51e-05	0.000184	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CXCL8—psoriasis	4.42e-05	0.00018	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	4.38e-05	0.000178	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	4.34e-05	0.000177	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCL8—psoriasis	4.32e-05	0.000176	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TYK2—psoriasis	4.26e-05	0.000174	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CAT—psoriasis	4.25e-05	0.000173	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—psoriasis	4.2e-05	0.000171	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—psoriasis	4.18e-05	0.00017	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—psoriasis	4.16e-05	0.00017	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—psoriasis	4.11e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—JUN—psoriasis	4.11e-05	0.000167	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TYK2—psoriasis	4.1e-05	0.000167	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	4.09e-05	0.000167	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—JUN—psoriasis	4.07e-05	0.000166	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	4.02e-05	0.000164	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—JUN—psoriasis	4.02e-05	0.000164	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NFKB1—psoriasis	3.95e-05	0.000161	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	3.94e-05	0.000161	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	3.92e-05	0.00016	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—psoriasis	3.9e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—psoriasis	3.89e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NFKB1—psoriasis	3.87e-05	0.000158	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—psoriasis	3.83e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TYK2—psoriasis	3.81e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—JUN—psoriasis	3.8e-05	0.000155	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—JUN—psoriasis	3.74e-05	0.000153	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL8—psoriasis	3.71e-05	0.000151	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	3.66e-05	0.000149	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	3.6e-05	0.000147	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—psoriasis	3.59e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	3.57e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	3.55e-05	0.000145	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—psoriasis	3.55e-05	0.000145	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—psoriasis	3.53e-05	0.000144	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—psoriasis	3.52e-05	0.000144	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—psoriasis	3.51e-05	0.000143	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—psoriasis	3.47e-05	0.000142	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—JUN—psoriasis	3.45e-05	0.000141	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—psoriasis	3.4e-05	0.000139	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—JUN—psoriasis	3.32e-05	0.000136	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	3.32e-05	0.000135	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	3.32e-05	0.000135	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NFKB1—psoriasis	3.32e-05	0.000135	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—psoriasis	3.3e-05	0.000135	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—psoriasis	3.29e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	3.27e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—psoriasis	3.24e-05	0.000132	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	3.2e-05	0.00013	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—psoriasis	3.16e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—JUN—psoriasis	3.09e-05	0.000126	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—psoriasis	3.01e-05	0.000123	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—psoriasis	2.98e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—psoriasis	2.97e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	2.97e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	2.9e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—psoriasis	2.87e-05	0.000117	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARG—psoriasis	2.87e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—psoriasis	2.72e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—psoriasis	2.71e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	2.7e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—psoriasis	2.69e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—psoriasis	2.67e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—psoriasis	2.65e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—psoriasis	2.51e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—psoriasis	2.48e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—psoriasis	2.47e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—psoriasis	2.46e-05	0.0001	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—psoriasis	2.43e-05	9.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—psoriasis	2.3e-05	9.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—psoriasis	2.28e-05	9.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—psoriasis	2.26e-05	9.22e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—psoriasis	2.19e-05	8.94e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—psoriasis	2.08e-05	8.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—psoriasis	2.04e-05	8.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—psoriasis	2.01e-05	8.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—psoriasis	1.87e-05	7.61e-05	CbGpPWpGaD
